These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 23280794

  • 1. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
    Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M.
    Ann Neurol; 2012 Nov; 72(5):779-87. PubMed ID: 23280794
    [Abstract] [Full Text] [Related]

  • 2. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
    Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F.
    Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
    [Abstract] [Full Text] [Related]

  • 3. Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
    Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C.
    N Engl J Med; 2012 May 17; 366(20):1870-80. PubMed ID: 22591293
    [Abstract] [Full Text] [Related]

  • 4. Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.
    Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T.
    J Neuropathol Exp Neurol; 2012 Jul 17; 71(7):604-17. PubMed ID: 22710964
    [Abstract] [Full Text] [Related]

  • 5. A rational approach to PML for the clinician.
    Calabrese L.
    Cleve Clin J Med; 2011 Nov 17; 78 Suppl 2():S38-41. PubMed ID: 22123934
    [Abstract] [Full Text] [Related]

  • 6. Presumptive progressive multifocal leukoencephalopathy in multiple sclerosis after natalizumab therapy.
    Eisele P, Szabo K, Hornberger E, Griebe M, Hennerici MG, Kieseier BC, Gass A.
    J Neuroimaging; 2014 Nov 17; 24(4):425-8. PubMed ID: 23323645
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
    Wattjes MP, Barkhof F.
    Curr Opin Neurol; 2014 Jun 17; 27(3):260-70. PubMed ID: 24739400
    [Abstract] [Full Text] [Related]

  • 8. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
    Boster AL, Nicholas JA, Topalli I, Kisanuki YY, Pei W, Morgan-Followell B, Kirsch CF, Racke MK, Pitt D.
    JAMA Neurol; 2013 Mar 01; 70(3):398-402. PubMed ID: 23338729
    [Abstract] [Full Text] [Related]

  • 9. Review of progressive multifocal leukoencephalopathy and natalizumab.
    Aksamit AJ.
    Neurologist; 2006 Nov 01; 12(6):293-8. PubMed ID: 17122725
    [Abstract] [Full Text] [Related]

  • 10. MRI pattern in asymptomatic natalizumab-associated PML.
    Wattjes MP, Vennegoor A, Steenwijk MD, de Vos M, Killestein J, van Oosten BW, Mostert J, Siepman DA, Moll W, van Golde AE, Frequin ST, Richert ND, Barkhof F.
    J Neurol Neurosurg Psychiatry; 2015 Jul 01; 86(7):793-8. PubMed ID: 25205744
    [Abstract] [Full Text] [Related]

  • 11. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O.
    Arch Neurol; 2009 May 01; 66(5):593-9. PubMed ID: 19433659
    [Abstract] [Full Text] [Related]

  • 12. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
    Wattjes MP, Wijburg MT, Vennegoor A, Witte BI, de Vos M, Richert ND, Uitdehaag BM, Barkhof F, Killestein J, Dutch-Belgian Natalizumab-associated PML study group.
    J Neurol Neurosurg Psychiatry; 2016 Aug 01; 87(8):879-84. PubMed ID: 26369555
    [Abstract] [Full Text] [Related]

  • 13. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.
    Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Brück W.
    Acta Neuropathol; 2012 Feb 01; 123(2):235-45. PubMed ID: 22057786
    [Abstract] [Full Text] [Related]

  • 14. Natalizumab (tysabri)-associated progressive multifocal leukoencephalopathy: insights from perfusion magnetic resonance imaging.
    Elster MJ.
    J Comput Assist Tomogr; 2013 Feb 01; 37(5):694-7. PubMed ID: 24045242
    [Abstract] [Full Text] [Related]

  • 15. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
    Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R.
    N Engl J Med; 2009 Sep 10; 361(11):1075-80. PubMed ID: 19741228
    [Abstract] [Full Text] [Related]

  • 16. Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
    Fine AJ, Sorbello A, Kortepeter C, Scarazzini L.
    Ann Neurol; 2014 Jan 10; 75(1):108-15. PubMed ID: 24242357
    [Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
    Hodel J, Bapst B, Outteryck O, Verclytte S, Deramecourt V, Benadjaoud MA, Pruvo JP, Vermersch P, Leclerc X.
    Mult Scler; 2018 Dec 10; 24(14):1902-1908. PubMed ID: 29343163
    [Abstract] [Full Text] [Related]

  • 18. The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?
    Phan-Ba R, Belachew S, Outteryck O, Moonen G, Sindic C, Vokaer M, Vermersch P.
    Neurology; 2012 Sep 04; 79(10):1067-9. PubMed ID: 22914844
    [No Abstract] [Full Text] [Related]

  • 19. MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.
    Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP.
    J Neurol Neurosurg Psychiatry; 2016 Oct 04; 87(10):1138-45. PubMed ID: 27530808
    [Abstract] [Full Text] [Related]

  • 20. Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: a case report.
    Piola M, Di Palma F, Mascoli N, Binda S, Arnaboldi M, Rezzonico M.
    J Neurol Sci; 2014 May 15; 340(1-2):213-4. PubMed ID: 24642511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.